$1.37
-0.01[-0.72%]
Last update: 10:29AM Get Real Time Here
Nektar Therapeutics
(NASDAQ:NKTR)Latest News for Nektar Therapeutics Stock (NASDAQ:NKTR)
Nektar Therapeutics Stock (NASDAQ: NKTR)
Categories: All
Wednesday, April 17, 2024
Thursday, April 11, 2024
Wednesday, March 06, 2024
Tuesday, March 05, 2024
Monday, March 04, 2024
- Nektar Therapeutics Q4 2023 GAAP EPS $(0.22) Beats $(0.23) Estimate, Sales $23.89M Beat $18.05M EstimateBenzinga Newsdesk - Mar 4, 2024, 4:24PM
- Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Mar 4, 2024, 1:29PM
- Nektar Therapeutics shares are trading higher after the company announced $30 million in private placement financing with TCGX.Benzinga Newsdesk - Mar 4, 2024, 11:49AM
- Nektar Therapeutics Announces $30M Private Placement Financing With TCGX; Nektar Is Selling 25M Shares Of Its Common Stock, In The Form Of A Pre-Funded Warrant, At A Price Of $1.20 Per ShareBenzinga Newsdesk - Mar 4, 2024, 8:37AM
- Earnings Scheduled For March 4, 2024Benzinga Insights - Mar 4, 2024, 4:53AM
Friday, March 01, 2024
Friday, January 12, 2024
Monday, December 11, 2023
Monday, November 20, 2023
Thursday, November 09, 2023
Tuesday, November 07, 2023
Monday, November 06, 2023
Friday, October 13, 2023
Monday, October 02, 2023
Wednesday, September 27, 2023
Friday, September 22, 2023
Thursday, September 21, 2023
- Director at Nektar Therapeutics Acquires Company Stock Options Worth 85,000 SharesBenzinga Insights - Sep 21, 2023, 11:01AM
- Board Member at Nektar Therapeutics Acquires Company Stock Options Worth 85,000 SharesBenzinga Insights - Sep 21, 2023, 11:00AM
- Nektar Therapeutics Board Member Awarded $59K Worth of Stock OptionsBenzinga Insights - Sep 21, 2023, 11:00AM
Wednesday, September 13, 2023
Tuesday, August 08, 2023
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga Insights - Aug 8, 2023, 5:32PM
- Nektar Therapeutics Q2 Adj EPS $(0.45) Misses $(0.28) Estimate, Sales $20.50M Miss $21.83M EstimateBenzinga Newsdesk - Aug 8, 2023, 5:29PM
- Nektar Therapeutics Q2 EPS $(0.27) Beats $(0.28) Estimate, Sales $20.50M Miss $21.79M EstimateBenzinga Newsdesk - Aug 8, 2023, 4:54PM
- Earnings Scheduled For August 8, 2023Benzinga Insights - Aug 8, 2023, 4:48AM
Monday, August 07, 2023
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Aug 7, 2023, 1:30PM
- Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Aug 7, 2023, 1:28PM
- Mizuho Reiterates Neutral on Nektar Therapeutics, Maintains $6 Price TargetBenzinga Newsdesk - Aug 7, 2023, 12:30PM
- Why Is Nektar Therapeutics Stock Surging Today?Vandana Singh - Aug 7, 2023, 12:20PM
- Nektar Therapeutics shares are trading higher after the company announced updated Rezpegaldesleukin efficacy data, which it says was previously incorrectly calculated by Lilly.Bill Haddad - Aug 7, 2023, 11:17AM
- Nektar Therapeutics Sues Eli Lilly For Breach Of Contract, Negligent Misrepresentation; Nektar Accuses Lilly Of Trying To Undermine Rezpeg, Which Nektar Developed To Treat Various Autoimmune DiseasesHappy Mohamed - Aug 7, 2023, 10:28AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Aug 7, 2023, 9:05AM
Wednesday, May 10, 2023
- Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023Benzinga Insights - May 10, 2023, 11:00AM
- Tempur Sealy International To Rally Around 32%? Here Are 10 Other Analyst Forecasts For WednesdayLisa Levin - May 10, 2023, 9:59AM
- Expert Ratings for Nektar TherapeuticsBenzinga Insights - May 10, 2023, 8:06AM
- Jefferies Upgrades Nektar Therapeutics to Hold, Lowers Price Target to $1Benzinga Newsdesk - May 10, 2023, 5:43AM
- CORRECTION: Nektar Therapeutics Q1 Adj. EPS $(0.25), Inline, Sales $21.59M Beat $19.84M EstimateHappy Mohamed - May 10, 2023, 12:32AM